MedTrace Logo

Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System

NCT03889093 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2025-03-24

No results posted yet for this study

Summary

The goal of this study is to understand the immunologic effects radioembolization has on the immune system. This will be done by evaluating the changes on biopsy, peripheral blood monocytes, and cytokines.

Conditions

Interventions

OTHER

Yttrium-90

This is to evaluate the immunologic effects of yttrium 90.

Sponsors & Collaborators

Principal Investigators

  • Shamar J Young, Young · University of Minnesota

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-09
Primary Completion
2022-02-24
Completion
2022-02-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03889093 on ClinicalTrials.gov